TEVA-DILTIAZEM XC: Out of specification
Brand(s)
Last updated
Summary
Product
TEVA-DILTIAZEM XC
Issue
Health products
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
TEVA-DILTIAZEM XC |
TEVA-DILTIAZEM XC |
DIN 02429357 |
Tablet |
DILTIAZEM HYDROCHLORIDE 360mg |
100038849 |
Issue
The recall is due to an out of specification for TEVA-DILTIAZEM XC 360MG TAB 100 bottle dissolution result during stability testing.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Teva Canada Limited 30 Novopharm Court, Toronto, ON M1B 2K9 |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75026
Get notified
Receive notifications for new and updated recalls and alerts by category.